101 related articles for article (PubMed ID: 19051724)
21. Smurf1 ubiquitin ligase causes downregulation of BMP receptors and is induced in monocrotaline and hypoxia models of pulmonary arterial hypertension.
Murakami K; Mathew R; Huang J; Farahani R; Peng H; Olson SC; Etlinger JD
Exp Biol Med (Maywood); 2010 Jul; 235(7):805-13. PubMed ID: 20558834
[TBL] [Abstract][Full Text] [Related]
22. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
Kayikçioğlu M
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
[TBL] [Abstract][Full Text] [Related]
23. Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.
Guignabert C; Bailly S; Humbert M
Expert Opin Ther Targets; 2017 Feb; 21(2):181-190. PubMed ID: 28001443
[TBL] [Abstract][Full Text] [Related]
24. Defective pulmonary vascular remodeling in Smad8 mutant mice.
Huang Z; Wang D; Ihida-Stansbury K; Jones PL; Martin JF
Hum Mol Genet; 2009 Aug; 18(15):2791-801. PubMed ID: 19419974
[TBL] [Abstract][Full Text] [Related]
25. Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension.
Richter A; Yeager ME; Zaiman A; Cool CD; Voelkel NF; Tuder RM
Am J Respir Crit Care Med; 2004 Dec; 170(12):1340-8. PubMed ID: 15361368
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of pulmonary arterial hypertension.
Xu XF; Cheng F; Du LZ
Hypertens Res; 2011 Sep; 34(9):981-6. PubMed ID: 21677658
[TBL] [Abstract][Full Text] [Related]
27. Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy.
Rondelet B; Kerbaul F; Van Beneden R; Motte S; Fesler P; Hubloue I; Remmelink M; Brimioulle S; Salmon I; Ketelslegers JM; Naeije R
Circulation; 2004 Oct; 110(15):2220-5. PubMed ID: 15466636
[TBL] [Abstract][Full Text] [Related]
28. TGFβ and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension.
Tielemans B; Delcroix M; Belge C; Quarck R
Drug Discov Today; 2019 Mar; 24(3):703-716. PubMed ID: 30529762
[TBL] [Abstract][Full Text] [Related]
29. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells.
Yu PB; Deng DY; Beppu H; Hong CC; Lai C; Hoyng SA; Kawai N; Bloch KD
J Biol Chem; 2008 Feb; 283(7):3877-88. PubMed ID: 18042551
[TBL] [Abstract][Full Text] [Related]
30. [Potential therapeutic target for pulmonary arterial hypertension--osteopontin].
Hoshikawa Y; Matsuda Y; Sakuma M; Kondo T
Nihon Rinsho; 2008 Nov; 66(11):2097-101. PubMed ID: 19051726
[TBL] [Abstract][Full Text] [Related]
31. [New insights in the pathogenesis of pulmonary arterial hypertension].
Bordenave J; Tu L; Savale L; Huertas A; Humbert M; Guignabert C
Rev Mal Respir; 2019 Apr; 36(4):433-437. PubMed ID: 31010759
[TBL] [Abstract][Full Text] [Related]
32. Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension.
Morrell NW
Adv Exp Med Biol; 2010; 661():251-64. PubMed ID: 20204735
[TBL] [Abstract][Full Text] [Related]
33. The amiloride derivative phenamil attenuates pulmonary vascular remodeling by activating NFAT and the bone morphogenetic protein signaling pathway.
Chan MC; Weisman AS; Kang H; Nguyen PH; Hickman T; Mecker SV; Hill NS; Lagna G; Hata A
Mol Cell Biol; 2011 Feb; 31(3):517-30. PubMed ID: 21135135
[TBL] [Abstract][Full Text] [Related]
34. Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension.
Toshner M; Voswinckel R; Southwood M; Al-Lamki R; Howard LS; Marchesan D; Yang J; Suntharalingam J; Soon E; Exley A; Stewart S; Hecker M; Zhu Z; Gehling U; Seeger W; Pepke-Zaba J; Morrell NW
Am J Respir Crit Care Med; 2009 Oct; 180(8):780-7. PubMed ID: 19628780
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia induces alteration of bone morphogenetic protein receptor signaling in pulmonary artery endothelial cell.
Takahashi K; Kogaki S; Matsushita T; Nasuno S; Kurotobi S; Ozono K
Pediatr Res; 2007 Apr; 61(4):392-7. PubMed ID: 17515860
[TBL] [Abstract][Full Text] [Related]
36. Bone Morphogenetic Proteins in Vascular Homeostasis and Disease.
Goumans MJ; Zwijsen A; Ten Dijke P; Bailly S
Cold Spring Harb Perspect Biol; 2018 Feb; 10(2):. PubMed ID: 28348038
[TBL] [Abstract][Full Text] [Related]
37. Bone morphogenetic protein signalling in pulmonary hypertension: advances and therapeutic implications.
Yang K; Wang J; Lu W
Exp Physiol; 2017 Sep; 102(9):1083-1089. PubMed ID: 28449240
[TBL] [Abstract][Full Text] [Related]
38. Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation.
Otterdal K; Andreassen AK; Yndestad A; Oie E; Sandberg WJ; Dahl CP; Pedersen TM; Ueland T; Gullestad L; Brosstad FR; Aukrust P; Damås JK
Am J Respir Crit Care Med; 2008 Jan; 177(2):202-7. PubMed ID: 17962639
[TBL] [Abstract][Full Text] [Related]
39. Gremlin plays a key role in the pathogenesis of pulmonary hypertension.
Cahill E; Costello CM; Rowan SC; Harkin S; Howell K; Leonard MO; Southwood M; Cummins EP; Fitzpatrick SF; Taylor CT; Morrell NW; Martin F; McLoughlin P
Circulation; 2012 Feb; 125(7):920-30. PubMed ID: 22247494
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary arterial hypertension: the clinical syndrome.
Lai YC; Potoka KC; Champion HC; Mora AL; Gladwin MT
Circ Res; 2014 Jun; 115(1):115-30. PubMed ID: 24951762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
